John Sullivan, a member of Cozen O'Connor's Commercial Litigation Department, discusses the latest decision in Zogenix, Inc. v. Baker, in which the commonwealth of Massachusetts has tried to regulate Zohydro ER, an extended release hydrocodone drug product that was approved by the FDA in 2013.
To read the article, click here.